Recent advances in the development of vaccines for chronic inflammatory autoimmune diseases

Vaccine
Volume 36, Issue 23  Pages 3191-3388 (31 May 2018)
https://www.sciencedirect.com/journal/vaccine/vol/36/issue/23

Reviews
Recent advances in the development of vaccines for chronic inflammatory autoimmune diseases
Review article
Pages 3208-3220
Naru Zhang, Kutty Selva Nandakumar
Abstract
Chronic inflammatory autoimmune diseases leading to target tissue destruction and disability are not only causing increase in patients’ suffering but also contribute to huge economic burden for the society. General increase in life expectancy and high prevalence of these diseases both in elderly and younger population emphasize the importance of developing safe and effective vaccines. In this review, at first the possible mechanisms and risk factors associated with chronic inflammatory autoimmune diseases, such as rheumatoid arthritis (RA), multiple sclerosis (MS), systemic lupus erythematosus (SLE) and type 1 diabetes (T1D) are discussed. Current advances in the development of vaccines for such autoimmune diseases, particularly those based on DNA, altered peptide ligands and peptide loaded MHC II complexes are discussed in detail. Finally, strategies for improving the efficacy of potential vaccines are explored.